PCM1 Depletion Inhibits Glioblastoma Cell Ciliogenesis and Increases Cell Death and Sensitivity to Temozolomide()

A better understanding of the molecules implicated in the growth and survival of glioblastoma (GBM) cells and their response to temozolomide (TMZ), the standard-of-care chemotherapeutic agent, is necessary for the development of new therapies that would improve the outcome of current GBM treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Hoang-Minh, Lan B., Deleyrolle, Loic P., Nakamura, Nariaki S., Parker, Alexander K., Martuscello, Regina T., Reynolds, Brent A., Sarkisian, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035360/
https://www.ncbi.nlm.nih.gov/pubmed/27661404
http://dx.doi.org/10.1016/j.tranon.2016.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035360/
https://www.ncbi.nlm.nih.gov/pubmed/27661404
http://dx.doi.org/10.1016/j.tranon.2016.08.006

Ejemplares similares